Literature DB >> 29728434

Focal segmental glomerulosclerosis in a patient with prefibrotic primary myelofibrosis.

Gopal Krishana Bohra1, Durga Shankar Meena1, Nitin Bajpai2, Abhishek Purohit3.   

Abstract

We report a case of 56-year-old man presented to us with chief complaints of frothy urine and leg swelling. A urinalysis revealed nephrotic-range proteinuria. Haematological investigations revealed thrombocytosis, leucocytosis and peripheral blood smear showed a leucoerythroblastic picture. JAK 2 mutation was positive. To confirm the diagnosis of myeloproliferative neoplasm, bone marrow biopsy was done, which was suggestive of primary myelofibrosis. The patient underwent kidney biopsy due to rapidly declining renal function and persistent proteinuria, which was suggestive of focal segmental glomerulosclerosis. Early glomerulopathy is rare in myeloproliferative neoplasm, and aggressive follow-up is required to prevent progression of kidney disease. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  malignant and benign haematology; proteinurea; renal system

Mesh:

Year:  2018        PMID: 29728434      PMCID: PMC5935172          DOI: 10.1136/bcr-2017-223803

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Secondary amyloidosis in the course of idiopathic myelofibrosis.

Authors:  B Ferhanoğlu; Y Erzin; Z Başlar; H A Tüzüner
Journal:  Leuk Res       Date:  1997-09       Impact factor: 3.156

Review 2.  Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.

Authors:  Ayalew Tefferi
Journal:  Am J Hematol       Date:  2016-12       Impact factor: 10.047

3.  Myeloproliferative neoplasms cause glomerulopathy.

Authors:  Samar M Said; Nelson Leung; Sanjeev Sethi; Lynn D Cornell; Mary E Fidler; Joseph P Grande; Sandra Herrmann; Ayalew Tefferi; Vivette D D'Agati; Samih H Nasr
Journal:  Kidney Int       Date:  2011-06-08       Impact factor: 10.612

4.  Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995.

Authors:  R A Mesa; M N Silverstein; S J Jacobsen; P C Wollan; A Tefferi
Journal:  Am J Hematol       Date:  1999-05       Impact factor: 10.047

5.  Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelves, ureters and bladder.

Authors:  J E Oesterling; J P Keating; A J Leroy; J D Earle; G M Farrow; J T McCarthy; M N Silverstein
Journal:  J Urol       Date:  1992-05       Impact factor: 7.450

6.  The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis.

Authors:  Takehiko Wada; Jeffrey W Pippin; Yoshio Terada; Stuart J Shankland
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

7.  Focal segmental glomerulosclerosis associated with idiopathic myelofibrosis.

Authors:  Isik Kaygusuz; Mehmet Koc; Hakki Arikan; Cafer Adiguzel; Fulya Cakalagaoglu; Tulin F Tuglular; Emel Akoglu
Journal:  Ren Fail       Date:  2010-01       Impact factor: 2.606

Review 8.  CT findings of extramedullary hematopoiesis in the thorax, liver and kidneys, in a patient with idiopathic myelofibrosis.

Authors:  H S Kwak; J M Lee
Journal:  J Korean Med Sci       Date:  2000-08       Impact factor: 2.153

9.  Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib.

Authors:  Arun Rajasekaran; Thuy-Trang Ngo; Maen Abdelrahim; William Glass; Amber Podoll; Srdan Verstovsek; Ala Abudayyeh
Journal:  BMC Nephrol       Date:  2015-08-01       Impact factor: 2.388

  9 in total
  1 in total

1.  Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL-Negative Myeloproliferative Neoplasms.

Authors:  Julie Belliere; Magali Colombat; Clément Kounde; Christian Recher; David Ribes; Antoine Huart; Dominique Chauveau; Véronique Demas; Isabelle Luquet; Odile Beyne-Rauzy; Suzanne Tavitian; Stanislas Faguer
Journal:  Kidney Int Rep       Date:  2020-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.